Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01580046
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Yong Huo
- Registry
-
NCT01580046
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01580046. Randomized; single masking; primary purpose prevention. Start 2012-04 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction
- Acronym
- RIPE
- Condition
- Kidney Failure, Chronic
- Intervention (Drug)
- iodixanol
- Intervention (Drug)
- iopromide
- Lead sponsor
- Yong Huo
Record details
- Record id
cardio:ct-nct01580046- Content hash
8ef62d5ffb080e36bd4e54ef772b4ea163bc40d4de1f3be8c36491d4c08feeb3